Transapical transcatheter aortic valve implantation (TA-TAVI) is increasingly used to treat aortic valve stenosis in high-risk patients. Mixed venous oxygen saturation (SvO 2 ) is still the 'gold standard' for the determination of the systemic oxygen delivery to consumption ratio in cardiac surgery patients. Recent data suggest that regional cerebral oxygen saturation (rScO 2 ) determined by near-infrared spectroscopy is closely related to SvO 2 . The present study compares rScO 2 and SvO 2 in patients undergoing TA-TAVI. n = 20 cardiac surgery patients scheduled for TA-TAVI were enrolled in this prospective observational study. SvO 2 and rScO 2 were determined at predefined time points during the procedure. Correlation and Bland-Altman analysis of the complete data set showed a correlation coefficient of r 2 = 0.7 between rScO 2 and SvO 2 (P < 0.0001), a mean difference (bias) of 5.8 with limits of agreement (1.96 SD) of −6.8 to 18.3% and a percentage error of 17.5%. At all predefined time points correlation was moderate (r 2 = 0.50) to close (r = 0.84), and the percentage error was <24%. RScO 2 determined by near-infrared spectroscopy is correlated to SvO 2 during varying haemodynamic conditions in patients undergoing TA-TAVI. This suggests that rScO 2 is reflective not only of the cerebral, but also of the systemic oxygen balance.
INTRODUCTION
Aortic valve stenosis remains the most common indication for heart valve surgery [1] . Aortic valve replacement with cardiopulmonary bypass is still the treatment of choice for symptomatic aortic stenosis but carries a significant risk of morbidity and mortality, particularly in patients with comorbidities [2] . Transapical transcatheter aortic valve implantation (TA-TAVI) is a less-invasive technique used to treat aortic stenosis in high-risk cardiac surgery patients [3] . Cerebral oximetry by near-infrared spectroscopy offers the possibility to non-invasively determine the cerebral oxygen balance. Recent data suggest that cerebral oxygenation might reflect not only regional but also the systemic oxygen balance [4] . Several groups have investigated the relationship between regional cerebral oxygen saturation (rScO 2 ) and mixed venous oxygen saturation (SvO 2 ) in adult cardiac patients [5] [6] [7] coming to conflicting results. Due to heterogenicity of design and patient populations in the published data, the reliability of the rScO 2 as a surrogate parameter of global haemodynamic state is still unclear.
Recently, we reported, in this journal, on the excellent agreement between rScO 2 and SvO 2 in a cardiac surgery patient undergoing TA-TAVI who required temporary cardiopulmonary resuscitation [8] .
The present prospective observational study was designed to further explore the relationship between rScO 2 and SvO 2 during varying haemodynamic states in patients undergoing TA-TAVI.
METHODS
All patients included in the analysis had given written informed consent in an observational study determining the impact of preoperative cerebral oxygenation on postoperative organ dysfunction (unpublished). Following approval of an amendment (amendment 5) to the primary request by the local ethical committee, n = 20 patients with severe symptomatic aortic stenosis scheduled for TA-TAVI were enrolled. All patients had undergone preoperative duplex sonography of supraaortic vessels and no patient with symptomatic carotid artery disease or internal carotid artery stenosis of 75% or more was included. Two patients had an incidence of ischaemic stroke within 24 months before cardiac surgery, without residue. Following oral premedication, sensors for the determination of rScO 2 with an INVOS ® 5100 monitor (Somanetics, Troy, MI, USA) were applied bihemisperically. Anaesthesia was induced with sufentanil and etomidate and maintained with sevoflurane and remifentanyl with the goal of early postoperative extubation. Muscle relaxation was achieved with rocuroniumbromide. All patients were ventilated in volume-controlled mode with a tidal volume of 6 ml/kg body weight and adjusted to achieve normocapnia. Depth of anaesthesia was guided by bispectral index (BIS) and anaesthetics were modified individually to achieve a BIS between 40 and 50. All patients were warmed by heating blankets to maintain a body temperature between 35.5 and 37.0°C.
After induction all patients were equipped with a pulmonary artery catheter (PAC) (CCombo; Edwards Lifesciences, Irvine, CA, USA) for semi-continuous determination of cardiac output and continuous measurement of SvO 2 connected to a Vigilance II ®monitor (Edwards Lifesciences).
Data collection
Haemodynamic data as well as SvO 2 and rScO 2 were recorded continuously throughout the surgical procedure. Stored electronic data were processed after cessation of the study period. Comparative measurements of SvO 2 and bilateral rScO 2 were determined from the recorded data file at predefined time points during the surgical period. rScO 2 levels of both hemispheres were averaged for analysis. The first data set (t1) was taken 20 min after induction of anaesthesia and accurate placement of the PAC. The second set (t2) was taken at the beginning of the first period of rapid pacing for valvuloplasty. The third data pair (t3) was set at the end of the first period of rapid pacing. The fourth data pair (t4) was taken at the beginning of the second period of rapid pacing for aortic valve implantation during the phase of free aortic insufficiency. The fifth set (t5) was taken at the end of the second period of rapid pacing and the last (t6) at the end of surgical procedure. The duration of the each phase of rapid ventricular pacing did not exceed 10 s but has not been documented in particular.
Statistical analysis
Data entry and analysis were conducted using MedCalc 10 for Windows. The relationship between values was determined by Pearson's correlation coefficient and Bland-Altman analysis for method comparison. A mean percentage error not exceeding 30% was defined to indicate clinically acceptable interchangeability of the methods [9] . After verification of normal distribution by Kolmogorov-Smirnov test relative values of rScO 2 and SvO 2 were compared with Student's t-test. A P < 0.05 was considered statistically significant.
RESULTS
Twenty patients (11 females and 9 males) undergoing TA-TAVI were enrolled. Mean age, height and weight were 82 (range 73-91) years, 167 (153-180) cm and 68 (52-90) kg, respectively. Specific patient characteristics are given in Table 1 .
Mean rScO 2 levels at baseline (mean of both hemispheres) before induction of anaesthesia were 57.7% (range 42-76). Stable rScO 2 and SvO 2 signals could be obtained in all patients during the intraoperative course and no interhemispheric differences in rScO 2 of >10% were observed.
In all patients an aortic prosthesis Edwards-Sapien valve (Edwards Lifesciences) was successfully implanted.
Analysis of all data pairs
Correlation analysis of all collected data pairs showed a correlation coefficient of r = 0.76 (95% confidence interval 0.67-0.82) between rScO 2 and SvO 2 (P < 0.0001) (see Fig. 1 ). Bland-Altman Table 2 shows the results of the analysis of the predefined time points, and Fig. 2 illustrates the course of SvO 2 versus rScO 2 throughout the procedure. The agreement between both variables was best after induction of anaesthesia (t1) and before the first rapid pacing (t2). Thereafter, the percentage error between the parameters increased until the end of the procedure (t6).
Analysis at particular time points
Comparably, the degree of correlation varied from close (t1, t2, t3, t5) to moderate (t4, t6).
Analysis of changes after rapid pacing
To compare the changes of rScO 2 and SvO 2 from before to after rapid pacing the value before rapid pacing was set as 100% and the value after rapid pacing determined as relative proportion of this 'baseline value'. The relative value of rScO 2 and SvO 2 was comparable for the first and second rapid pacing (see Figs 3 and 4 ).
DISCUSSION
The present prospective observational study was designed to evaluate the agreement between rScO 2 and SvO 2 during a procedure with rapidly changing haemodynamic states. With the exception of a recent case report from our group [8] , no further data are available about the course of rScO 2 during TA-TAVI and about its relation to SvO 2 . The study revealed moderate-to-close correlations between rScO 2 and SvO 2 and percentage errors in a clinically acceptable range [9] . However, the measurements before the rapid pacing phase showed a better agreement between SvO 2 and rScO 2 than during the periods with haemodynamic instability. One possible explanation may be the retention of carbon dioxide during the rapid pacing period, leading to a discrete increase in arterial carbon dioxide tension and a subsequent increase in rScO 2 . In this study we did not take blood gas analyses at all time points and therefore this speculation needs to be verified by a prospective trial. However, the relative changes from before to after both rapid pacing periods were comparable for rScO 2 and SvO 2 . During these short haemodynamic low-flow periods, the drop in regional cerebral oxygenation reflects the drop in the surrogate parameter for global oxygen balance, the SvO 2 . Goal-directed haemodynamic optimization targeting at SvO 2 >70% has been shown to reduce postoperative organ dysfunction and length of hospital stay in cardiac surgery patients [10] . Therefore, SvO 2 -guided therapy has received a 'grade A recommendation' in the German S3 guideline [11] . The use of a PAC for determination of SvO 2 may thus be regarded as a 'gold standard' in this clinical situation. However, the insertion of a PAC is not without risk. Based on the guidelines and due to pertinent experience [8] in our centre, we monitor the haemodynamic state during TA-TAVI procedure with PAC.
Near-infrared spectroscopy is increasingly used for monitoring of the adequacy of cerebral oxygen delivery [12] . Interestingly, intraoperative cerebral desaturation has not only been linked to postoperative cerebral complications after cardiac surgery but also to worse general clinical outcome [13] . A recently published observational trial of our own group showed that preoperative rScO 2 levels are closely related to relevant measures of cardiopulmonary function, postoperative morbidity and short-and long-term mortality [4] .
Several studies have evaluated the relationship between rScO 2 and SvO 2 as a measure for global oxygen delivery-to-demand ratio with conflicting results [5, 6] .
Baraka et al. [5] reported a strong agreement between rScO 2 and SvO 2 during tepid hypothermia during coronary artery bypass grafting surgery, but interestingly only a poor agreement during moderate hypothermia. One possible explanation may be changes in cerebral perfusion following temperature changes during the cardiopulmonary bypass period, i.e. cooling, rewarming. In line with these assumptions, we have recently shown a clinically acceptable correlation between rScO 2 and SvO 2 in spontaneously breathing patients after cardiac surgery [7] . Comparably, we observed a good agreement between rScO 2 and SvO 2 in patients requiring temporary circulatory support by extracorporeal membrane oxygenation due to refractory cardiogenic shock [14] . These results are in contrast to the findings of Dullenkopf et al. [6] who observed only a poor correlation (r = 0.3) between SvO 2 and rScO 2 after cardiac surgery, but an acceptable sensitivity to detect changes in SvO 2 .
The discrepancies between the results may in part be caused by variations in clinical management. Cerebral perfusion in relation to global perfusion might be altered by changes in carbon dioxide tension. This can be influenced by ventilation or, in patients awake, by sedation. Sedation itself as well as temperature changes might influence cerebral activity and hereby cerebral metabolism, which has important impact on cerebral blood flow and cerebral oxygen delivery-to-demand ratio [15] . Due to the observational nature of the present study we did not define specific goals for pCO 2 levels and body temperature. However, all patients were treated according institutional standards aiming for normocapnia, normothermia and depth of anaesthesia. Thus, these potentially confounding variables influencing rScO 2 were controlled as far as possible.
Another point is the statistical interpretation of the results. We interpreted a percentage error of smaller 30% as clinically acceptable as recommended by Critchley and Critchley [9] . Actually, at most measured time points the percentage error between the methods did not exceed 20%, and the correlations between the methods were moderate to close.
Of note, at all measured time points the rScO 2 was lower than the SvO 2 . If the rScO 2 would have been used to estimate SvO 2 , SvO 2 would have been rather underestimated, so the patient would have been rather over-treated. This might, in many cases, avoid hypoperfusion, but certainly the risks of unnecessary inotropic treatment should not be disregarded.
Limitations
This study has several limitations:
(1) The small sample size is a clear limitation of the study. Larger observations and prospective interventional trials are needed to determine factors influencing the relationship between rScO 2 and SvO 2 . (2) Since the rapid pacing periods were rather short, and the sampling rates of the Vigilance II-Monitor and the INVOS-Monitor differ, the measurements during the rapid pacing periods may be incongruent. This may, at least in part explain the less optimal correlations during these periods. However, the haemodynamic deterioration was evident in both methods and was reflected readily. (3) Comparable to other studies investigating the agreement between rScO 2 and SvO 2 , we used the mean of the bihemispheric measurements for calculation of rScO 2 . In case of large interhemispheric differences this may introduce a systematic error. However, since in the present study the differences between both hemispheres were small, the potential error is rather low.
In conclusion, the results of the present study show that rScO 2 determined by near-infrared spectroscopy correlates well with SvO 2 during the rapidly changing haemodynamic conditions in patients undergoing TA-TAVI. Whether this non-invasive technology may be used as an alternative for SvO 2 measurements or is giving additional information to SvO 2 monitoring warrant further investigation.
